Stock screener

ADPT

Conviction 95HealthcareScan · Mon, Aug 10, 2026
ADPT$25.46+2.13%
ResistanceSupportVol 14Insider sell
63 bars
3
3
2
2
Vol MA14 2.97M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Adaptive Biotechnologies CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.adaptivebiotech.com ↗
Price25.46
Change+2.13%
Gap-0.28%
Rel volume1.75×
Avg volume2.94M
Avg $ vol68.29M
SMA 2023.05
SMA 5020.44
SMA 20016.81
Price vs 50+24.58%
Price vs 200+51.47%
MA stackbullish
50/200 cross—
Supertrendup · 21.29
RSI (14)65
MACD hist0.09
MACD crossbull · 1d
Stoch %K / %D85 / 84
ADX (14)38
+DI / −DI28 / 11
RSI divergenceBearish
MACD divergenceBearish
ATR %+5.33%
ADR %5.80%
52w high25.46
52w low12.15
From 52w high+0.00%
Above 52w low+109.55%
New 52w highYes
SqueezeOff
Bollinger width19.08%
%B1.05
Donchian pos87.01%
Donchian high26.15
Donchian low20.84
AVWAP (52w high)25.44
vs AVWAP high+0.07%
AVWAP (52w low)16.60
vs AVWAP low+53.40%
OBV trendUp
Chaikin MF (20)0.28
Today vs 20d1.75×
Avg vol (14d)2.97M
Avg vol (20d)2.94M
Avg $ vol (20d)68.29M
Market cap4.06B
RS 3m (vs SPY)+64.01%
RS 6m (vs SPY)+37.25%
RS line new highNo
Trend template8/8
Technical rank92.7
1 week+10.17%
1 month+20.89%
3 months+84.36%
6 months+61.45%
1 year+103.03%
YTD+60.03%
P/E-68.29
P/B28.43
P/S14.67
P/FCF-83.02
EPS-0.3900
Div yield—
ROE-41.63%
ROA-9.29%
Debt/Eq0.00
Current4.79
EV/EBITDA-94.68
Gross margin—
Net margin-21.48%
Rev growth54.77%
EPS growth62.69%
Price target25.07
Target upside-1.53%
Analyst ratingBuy
Institutional101.94%
Ent. value3.89B
Revenue71.55M
Net income-39.79M
Gross profit—
Free cash flow-48.95M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out160.04M
Employees624
ListedThu, Jun 27, 2019
Free float113.41M
Float %74.3%
Short interest11.4M
Days to cover4.3d
Short volume54.6%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.10 vs −$0.13
Last surprise+23.1% beat
Setup gradeA+
Conviction95 / 100
Pattern quality—
Tech rank92.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance24.06
Support17.84
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ADPT

All disclosures →
No recent disclosed trades by Congress in ADPT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ADPT · 3 buys · 7 sells

InsiderSideShares
LO FRANCIS
Chief People Officer · Common Stock · 2026-07-15
Exercise23.68K
LO FRANCIS
Chief People Officer · Common Stock · 2026-07-15
Exercise22.71K
LO FRANCIS
Chief People Officer · Stock Option (right to buy) · 2026-07-15
Exercise59.37K
LO FRANCIS
Chief People Officer · Common Stock · 2026-07-15
Sell105.76K
LO FRANCIS
Chief People Officer · Stock Option (right to buy) · 2026-07-15
Exercise22.71K
LO FRANCIS
Chief People Officer · Stock Option (right to buy) · 2026-07-15
Exercise23.68K
LO FRANCIS
Chief People Officer · Common Stock · 2026-07-15
Exercise59.37K
ROBINS HARLAN S
Chief Scientific Officer · Common Stock · 2026-07-02
Sell239.35K
ROBINS HARLAN S
Chief Scientific Officer · Common Stock · 2026-07-02
Sell146.89K
LO FRANCIS
Chief People Officer · Stock Option (right to buy) · 2026-07-02
Exercise12.63K

SEC filings

EDGAR filings in ADPT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.